Percutaneous treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic

Description

Background
Antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE, are an increasing problem world-wide, causing intractable wound infections. Complex phytochemical extracts such as tea tree oil and eucalypt-derived formulations have been shown to have strong bactericidal activity against MRSA in vitro. Polytoxinol (PT) antimicrobial, is the trade name of a range of antimicrobial preparations in solution, ointment and cream form.

      Methods
      We report the first use of this drug, administered percutaneously, via calcium sulphate pellets (Osteoset,TM), into bone, to treat an intractable MRSA infection of the lower tibia in an adult male.


      Results and Discussion
      Over a three month period his symptoms resolved with a healing response on x-ray and with a reduced CRP.

Resources

Name Format Description Link
Official Government Data Source HTML Visit the original government dataset for complete information, documentation, and data access. Open resource

Tags

Topics

Categories